Risk Stratification-directed NAC for Prevention of Poor Hematopoietic Reconstitution

NCT03967665 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Stem Cell Transplant Complications

Interventions

DRUG: N-acetyl-L-cysteine

Sponsor

Peking University People's Hospital